The Enterprise Value as of December 2025 (TTM) for Collegium Pharmaceutical, Inc. (COLL) is 2.16B

According to Collegium Pharmaceutical, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.16B. This represents a change of 26.77% compared to the average of 1.71B of the last 4 quarters.

Collegium Pharmaceutical, Inc. (COLL) Historical Enterprise Value (quarterly & annually)

How has COLL Enterprise Value performed in the past?

The mean historical Enterprise Value of Collegium Pharmaceutical, Inc. over the last ten years is 822.16M. The current 2.16B Enterprise Value has changed 26.21% with respect to the historical average. Over the past ten years (40 quarters), COLL's Enterprise Value was at its highest in in the September 2024 quarter at 2.08B. The Enterprise Value was at its lowest in in the March 2017 quarter at 169.19M.

Collegium Pharmaceutical, Inc. (COLL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Collegium Pharmaceutical, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Collegium Pharmaceutical, Inc. (COLL) Average Enterprise Value

How has COLL Enterprise Value performed in the past?

The current Enterprise Value of Collegium Pharmaceutical, Inc. (COLL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Collegium Pharmaceutical, Inc. (COLL) Enterprise Value vs. Peers

How is COLL’s Enterprise Value compared to its peers?

Collegium Pharmaceutical, Inc.’s Enterprise Value is greater than Amphastar Pharmaceuticals, Inc. (1.69B), greater than Dynavax Technologies Corporation (1.47B), greater than Cronos Group Inc. (166.07M), greater than GoodRx Holdings, Inc. (720.75M), greater than Innoviva, Inc. (1.39B), greater than Pacira BioSciences, Inc. (952.95M), greater than MiMedx Group, Inc. (875.27M), greater than Pulse Biosciences, Inc. (801.17M), greater than Atai Beckley N.V (802.51M), greater than Nektar Therapeutics (1.22B),

Build a custom stock screener for Collegium Pharmaceutical, Inc. (COLL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Collegium Pharmaceutical, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Collegium Pharmaceutical, Inc. (COLL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Collegium Pharmaceutical, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.